These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 18516820)

  • 1. New generation methods for drug susceptibility testing for tuberculosis.
    Katoch VM
    Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820
    [No Abstract]   [Full Text] [Related]  

  • 2. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of primary drug resistance of Mycobacterium tuberculosis from two hospitals in Tenerife, Canary Islands, Spain (1990-1997).
    Lecuona M; Alvarez R; Quintero J; Torres A; Hernández AM; Montesinos I; Sierra A
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):186-7. PubMed ID: 10694101
    [No Abstract]   [Full Text] [Related]  

  • 4. The "source" of drug-resistant TB outbreaks.
    van Helden PD; Victor T; Warren RM
    Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
    [No Abstract]   [Full Text] [Related]  

  • 5. [The urgency of developing new technologies to detect drug resistance in Mycobacterium tuberculosis].
    Zheng RJ; Hu ZY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):6-8. PubMed ID: 21418810
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutting costs on mono-resistant tuberculosis diagnosis could eventually end up being more expensive.
    Rouzaud F; Robledo J
    Indian J Med Microbiol; 2010; 28(4):412-3. PubMed ID: 20966587
    [No Abstract]   [Full Text] [Related]  

  • 7. Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.
    Schön T; Juréen P; Chryssanthou E; Giske CG; Sturegård E; Kahlmeter G; Hoffner S; Angeby KA
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):502-9. PubMed ID: 21396210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistant tuberculosis in Egyptian children using Etest.
    Morcos W; Morcos M; Doss S; Naguib M; Eissa S
    Minerva Pediatr; 2008 Dec; 60(6):1385-92. PubMed ID: 18971899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic drug susceptibility testing: a necessary component of the 'DOTS plus' strategy?
    Grosset PJ
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):549-50. PubMed ID: 10423215
    [No Abstract]   [Full Text] [Related]  

  • 10. Shortening the treatment of tuberculosis.
    Mitchison DA
    Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyrazinamide resistance among drug-resistant Mycobacterium tuberculosis isolates at a referral hospital.
    Arora J; Sidiq Z; Visalakshi P; Bhalla M; Behera D; Myneedu VP
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):380-1. PubMed ID: 24075630
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug susceptibility of tuberculosis isolates in Kansas, 1992-1993.
    Kans Med; 1994 Jun; 95(6):147-8. PubMed ID: 7933767
    [No Abstract]   [Full Text] [Related]  

  • 13. Performance evaluation program for Mycobacterium tuberculosis drug-susceptibility testing process.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jan; 43(1):17-8. PubMed ID: 8272047
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance to anti-tuberculosis medications in the Horn of Africa.
    Ollé-Goig JE; Codina-Grau G; Martín-Casabona N
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of multidrug-resistant Mycobacterium tuberculosis in Sinaloa State, Mexico.
    Zazueta-Beltran J; Muro-Amador S; Flores-Gaxiola A; Llausas-Magaña E; León-Sicairos N; Canizalez-Roman A
    J Infect; 2007 Apr; 54(4):411-2. PubMed ID: 16730800
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis.
    Palomino JC; Martin A; Von Groll A; Portaels F
    J Microbiol Methods; 2008 Oct; 75(2):161-6. PubMed ID: 18627779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-years experience of fluoroquinolone susceptibility testing of multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
    Prammananan T; Chaiprasert A; Leechawengwongs M
    Int J Antimicrob Agents; 2011 Jan; 37(1):84-5. PubMed ID: 21075609
    [No Abstract]   [Full Text] [Related]  

  • 19. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
    Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ad fontes!
    Hoffner SE; Salfinger M
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):260. PubMed ID: 20132612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.